# ENDRA Life Sciences Inc.: Form 8-K, filed Aug 9, 2024

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: 8-K
- Filed: 2024-08-09
- Accepted by EDGAR: Aug 9, 2024, 08:02 ET
- Period: 2024-08-05
- Accession: 0001654954-24-010213
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000165495424010213/ndra_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000165495424010213/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000165495424010213/ndra_8k.htm

Filed Aug 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001654954-24-010213. Last ingested by Listed: Nov 10, 2026, 17:03 ET. No prices; not investment advice.
